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Abstract
Background: In Plasmodium falciparum-infected children, the relationships between blood cell histopathology, blood plasma
components, development of immunocompetence and disease severity remain poorly understood. Blood from Nigerian children
with uncomplicated malaria was analysed to gain insight into these relationships. This investigation presents evidence for
circulating neutrophil extracellular traps (NETs) and antinuclear IgG antibodies (ANA). The presence of NETs and ANA to
double-stranded DNA along with the cytokine profiles found suggests autoimmune mechanisms that could produce
pathogenesis in children, but immunoprotection in adults.
Methods: Peripheral blood smear slides and blood samples obtained from 21 Nigerian children under six years of age,
presenting with uncomplicated malaria before and seven days after initiation of sulphadoxine-pyrimethamine (SP) treatment
were analysed. The slides were stained with Giemsa and with DAPI. Levels of the pro-inflammatory cytokines IFN-γ, IL-2, TNF,
CRP, and IL-6, select anti-inflammatory cytokines TGF-β and IL-10, and ANA were determined by immunoassay.
Results: The children exhibited circulating NETs with adherent parasites and erythrocytes, elevated ANA levels, a Th2
dominated cytokine profile, and left-shifted leukocyte differential counts. Nonspecific ANA levels were significant in 86% of the
children pretreatment and in 100% of the children seven days after SP treatment, but in only 33% of age-matched control samples
collected during the season of low parasite transmission. Levels of ANA specific for dsDNA were significant in 81% of the
children both pre-treatment and post treatment.
Conclusion: The results of this investigation suggest that NET formation and ANA to dsDNA may induce pathology in
falciparum-infected children, but activate a protective mechanism against falciparum malaria in adults. The significance of in vivo
circulating chromatin in NETs and dsDNA ANA as a causative factor in the hyporesponsiveness of CpG oligonucleotide-based
malaria vaccines is discussed.
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Background
Pathogenesis in humans infected with Plasmodium falci-
parum involves a complex multifactorial immune system
response to the parasite as well as to host cell and tissue
damage. Although much is known about the immunolog-
ical response to falciparum infection [1-3], relationships
between immunocompetence [4] and disease severity
remain poorly understood. Patient age [5], genetics [6],
vitamin sufficiency [7-10], gravidae [11-13], control of
oxidative stress [14-16], and factors related to the availa-
bility of complement proteins and their receptors [17-23]
all affect immunocompetence, as does the presence of
immunosuppressive [4] and autoimmune factors [24].
The levels of certain cytokines associated with falciparum
malaria can provide clues to the immune system reaction,
but analyses of cytokine levels alone can yield paradoxical
results concerning the protection and pathology of the
underlying highly integrated responses [5,15,18,25-35].
An IFN-γ-Th1-dependent immune response in the mouse
model, for example, has been associated with both immu-
noprotection [3] and immunopathology [36]. Likewise,
elevated CRP levels can both activate the classical comple-
ment cascade and yet provide protection for endothelial
cells from membrane attack complex deposition through
up regulation of surface receptor expression to counter the
effects of the activated cascade [23].
The immune response to falciparum infection may
depend not only on the cytokine profile but also on
hematologic activity. Recently, a novel activity of neu-
trophils, formation of neutrophil extracellular traps
(NETs), has been described [37-42]. NETs can bind and
kill a variety of microbes [38,42], but NET formation has
not been described previously as a response to falciparum
malaria infection.
The goal of this study was to investigate the cytokine pro-
files and hematologic activity involved in the immune
response to falciparum infection in children six years of
age or younger presenting with uncomplicated malaria.
Samples from 21 falciparum-infected children from a
mesoendemic region of Nigeria were analysed by ELISA
for levels of IL-10, IL-6, IL-2, TNF, IFN-γ, TGF-β, CRP, and
circulating antinuclear antibodies (ANA) and by periph-
eral slide analysis for leukocyte differential count and the
presence of abnormally fragile leukocytes and NETs. The
results of this investigation suggest mechanisms by which
immunoprotection develops, as well as mechanisms by
which autoimmune activity initially may lead to increased
pathogenesis in children, but over time may induce
immunoprotection in the exposed adult population. Evi-
dence for NET formation and autoimmune activity also
suggests a mechanism by which the presence of ANA to
dsDNA may contribute to a hyporesponsiveness to CpG-
based malarial vaccines [4,43,44].
Methods
Study site
Jos University Teaching Hospital (JUTH) and Florida State
University Human Subjects Committees approved the
protocol for a physician-based malaria team from Jos,
Nigeria, to perform a malaria clinical outreach/study of
children under six years of age in the Barkin Ladi Village
Clinic [45]. The Barkin Ladi Village Clinic is located in a
region mesoendemic to P. falciparum infection with aver-
age spleen rate of 28-30% during high transmission sea-
son and hyperparasitaemia occurring in 0.6% of the
patients [46] and represents the situation found in many
parts of sub-Saharan Africa, where advanced hospital
facilities are not available to the patient, physician, or
researcher.
Patients and sampling
Patients presenting with slide positive falciparum malaria
were evaluated by a physician for general signs of neuro-
logical well-being, hepatomegaly, splenomegaly, fever,
and wasting. All patients in the study were characterized
as having uncomplicated falciparum malaria through
established criteria [26,46,47]. Patients were given a single
therapeutic dose of sulphadoxine-pyrimethamine (SP,
Fansidar®), previously assessed by members of the current
research team as the drug of choice for the Plateau region
of Nigeria because of minimal trophozoite recrudescence
[46]. Patients placed on the study received a seven-day
post-treatment follow-up visit by the physicians. All
patients were given an insecticide treated mosquito net to
reduce the rate of re-infection whether they participated in
the study or not.
Blood from slide-positive children under six years of age
that was sero-negative for HIV (Oraquick Rapid Antibody
HIV Test #3001-0951, OraSure Technologies Inc, Bethle-
hem, PA), and that had a packed cell volume greater than
25% [47] was collected pre- and seven-days post SP-treat-
ment. Blood samples were collected in sterile blood col-
lecting vacutainers with 15% EDTA, 3.8% Na+ citrate, or
without additive for serum collection (Becton Dickinson,
Franklin Lakes, N.J.). The EDTA-containing samples were
immediately placed on ice. The Na+ citrate and serum
samples were placed in a foam-insulated cooler with an
ice pack tethered inside to maintain a cool environment
without contact of the tubes with the coolant. Blood sam-
ples were taken at the end of the day so that all samples
collected were centrifuged within an hour and a half of
collection. Na+ citrate and serum samples were spun at
ambient temperature (27°C) for 15 minutes at 1000 × g,
whereas EDTA samples were spun at 4°C for 15 minutes
at 1000 × g in a refrigerator centrifuge on site (poweredMalaria Journal 2008, 7:41 http://www.malariajournal.com/content/7/1/41
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with a generator). The centrifuge had adequate bucket
space for simultaneous spinning of all serum and Na+ cit-
rate samples at ambient temperature first, followed by
centrifugation of EDTA samples at 4°C. Retrieved serum
and plasma samples were transferred aseptically to Nal-
gene cryovials (Fisher Scientific) and stored at -70°C in a
freezer at JUTH. Samples were transported by carrier in a
Saf T Case (STP 350, SAF-T-PAK, Inc) with all enclosed
samples, containers, and gel packs (Arctic Pack, Packaging
Products Corp., New Bedford, Mass) frozen at -70°C
before air transport to FSU for analysis.
Histology
Films of freshly collected finger-prick blood samples were
stained in Giemsa solution diluted in pH 7.3 phosphate
buffer. A rapid staining protocol using double strength
Giemsa (4%) for 10 minutes was used initially during
screening to select those who had malaria parasitaemia.
For parasite density estimation, a second slide was stained
with 2% Giemsa solution for 30 minutes. In both screen-
ing and subsequent parasite density estimation, the slides
were fixed with absolute methanol and allowed to air dry
before staining [48]. Two trained microscopists evaluated
the slides for the presence of falciparum malaria. Periph-
eral blood smears from patients present at the clinic, but
slide negative for falciparum malaria, were used as stain-
ing controls. A leukocyte differential analysis of slides
shipped to the US was performed by two microscopists,
one of whom was a physician with expertise in abnormal
leukocyte fragility, detection of NETs dispersed among
normal leukocytes, and the identification of neutrophil
toxic granulation. The pre-treatment differential between
metamyelocytes, segmented neutrophils, bands, hyper-
segmented neutrophils, eosinophils, basophils, lym-
phocytes, monocytes, NETs, and smudge forms was
calculated per 100 leukocytes for each child studied pre
treatment (n = 21) and post treatment (n = 19 – two slides
were unavailable for differential count in U.S.). The slides
were scored for Rouleaux and coined-agglutinin aggrega-
tion and for the presence or absence of NET-associated
extracellular fibers sequestering parasites.
To determine the presence of chromatin in NET forma-
tion, slides were destained by the protocol of Kobayashi et
al, 1989 [49]. Briefly, the slides were immersed in 50%
ethanol at 37°C for one hour and 100% methanol at
37°C for one hour. The slides were then stained with
DAPI (0.01 mg/ml in Tris-EDTA buffer solution with 10
mM 2-mercaptoethylamine, pH 7.4) to visualize the
DNA.
Slides were viewed with a Nikon Microphot-FX (Nikon,
Inc, Melville, N.Y.) microscope. Images were recorded
with a Zeiss AxioCam MR camera (Carl Zeiss Vision
GmbH, Germany). Minor contrast and gamma adjust-
ments of the images were made with Photoshop software.
Parasite count
Parasite counts standardized per 200 leukocytes were
obtained from thick/thin blood films. The number of par-
asites per microliter of blood was calculated by assuming
an average white blood cell count of 10,000/µl in chil-
dren.
Cytokine determination
Plasma and serum samples from children ≤5 years of age
(n = 21) were analysed in duplicate both pre-and post-
treatment to assess individual cytokine changes. ELISA
kits were used to measure IL-10, IL-6, TNF, IL-2, IFN-γ
(Pierce Biotechnology, Inc., Rockford, IL), TGF-β, and
CRP (US Biological, Swampscott, MA) according to man-
ufacturers' protocols. Positive and negative controls were
included. Standard curves were determined from serial
dilutions of recombinant human cytokines included in
each test kit.
ANA level determination
Serum samples from children ≤5 years of age (n = 21)
were analysed evaluated by the ELISA using an assay kit
for all antinuclear antibodies (ANA) as well as a kit spe-
cific for IgG ANA to dsDNA, according to the manufac-
turer's instructions (Wampole Laboratories, Princeton,
N.J.). Both pre-and post-treatment samples were analysed
to assess changes in individual patient general and anti-
dsDNA ANA levels. Additionally, blood obtained during
the season of low parasite transmission [46] from age-
matched children (n = 18) that were slide negative for
detectable trophozoites or gametocytes was evaluated for
general ANA. Scoring of ANA levels was based on ANA kit
index values: negative ≤ 0.90; equivocal 0.91 – 1.09; pos-
itive ≥ 1.10.
Statistical analysis
Sigma Plot was used to analyse data and assemble graphs.
Independent cytokine and ANA values for pre- (n = 21)
and post-treatment (n = 21) samples, and anomalies asso-
ciated with NETs and cytokine induced increased fragility
of lymphocytes and neutrophils, as noted on peripheral
slide evaluation by leukocyte differential analysis were
tested for equality of variances by Levenne's test and
equality of means by Student's t test (2-tailed). Results
were expressed at a 95% confidence level as the mean ±
standard deviation. Cramer's V test was used for measures
of nominal association, as might be found in aggregation
phenomena and/or the presence of extracellular fibers in
fibrinoid complexes. The results of the Cramer's V tests
were evaluated according to the following criteria: <0.10 =
no relationship, 0.10 – <0.20 = weak association, 0.20 –
<0.25 = moderate association, 0.25 – <0.30 = moderatelyMalaria Journal 2008, 7:41 http://www.malariajournal.com/content/7/1/41
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strong association, 0.30 – <0.35 = strong association, 0.35
– <0.40 = very strong association, 0.40 – <0.45 extremely
strong relationship or the two variables are measuring the
same concept, 0.45 – <0.99 = two variables probably
measuring the same concept, 1.00 = perfect relationship;
independent variables will predict the dependent varia-
ble.
Results
Peripheral slide analysis – leukocyte differential counts
Blood samples from 21 children five years of age and
younger diagnosed with clinically uncomplicated slide-
positive P. falciparum malaria were obtained before and
seven days after treatment with SP during the season of
high transmission. Peripheral slide analysis of Giemsa-
stained thick and thin blood films revealed the children
had parasitaemias ranging from 2,000/mL to 90,000/mL
(mean = 30,738) before SP treatment and negligible tro-
phozoite levels seven days after SP treatment in all but one
patient (who had <250 trophozoites/mL). Gametocytes
were present in 10% (2/21) of the pre-treatment and 32%
(6/19) of the post treatment patients, consistent with the
inactivity of SP as a gametocidal drug (data not shown).
Seven (34%) of the 21 children presented with hepatome-
galy (2 cm in 5 children; 4 cm in 2 children). Two of the
children with 2 cm hepatomegaly also presented with 3
cm splenomegaly. No statistical correlation was found
between cytokine levels and the presence of gametocytes,
hepatomegaly, and/or splenomegaly.
Percentages (number per 100 leukocytes counted) of nor-
mal and abnormal lymphocytes and neutrophils were
determined by a leukocyte differential count before and
seven days after initiation of SP treatment with special
attention to the presence of NETs (Figure 1). The post-
treatment differential analysis was based on slides from
19 of 21 children, because two post treatment slides were
not available for analysis in the U.S. Haematologic values
were compared to a normal differential reference range
[50]. Remarkably, monocyte involvement was low in the
children both pretreatment (mean of 1.21% ± 2, range of
1-5/100), in 29% (6/21) of the children, and post treat-
Leukocyte differential counts before and seven days after SP treatment Figure 1
Leukocyte differential counts before and seven days after SP treatment. One hundred leukocytes on fingerprick 
peripheral blood smear slides for each child made before and seven days after SP treatment (x) were classified into one of ten 
groups. The percentage of each group was calculated. Box plots indicating the 25th, 50th, and 75th percentile (solid lines from 
bottom to top of box, respectively), the 90th and 10th percentile values (high and low error bars respectively), and high and low 
outlier points are shown for each of the following leukocyte classes: 1) metamyelocytes, 2) segmented neutrophils, 3) bands, 4) 
hypersegmented neutrophils, 5) NETs, 6) monocytes, 7) lymphocytes, 8) smudge forms, 9) eosinophils, and 10) basophils.
Leukocyte differential before and after SP treatment 
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ment (2.0% ± 1.8, 1-6/100), in 68% (13/19) of the chil-
dren. Monocyte levels did not change significantly after
treatment (P < 0.105). Levels of eosinophils and
basophils were normal in the children both before and
after treatment.
Lymphocytes were observed in all (21/21) the children
pretreatment (31.7% ± 13, range of 6-61/100), and most
(17/19) children post treatment (36% ± 16, range of 0-63/
100), with no significant change overall between pre- and
post-treatment (P < 0.359). Lymphocyte fragility was evi-
dent as leukemoid bare nuclei in smudge cells [51] to var-
ying degrees in 95% (20/21) of the children pre-treatment
(10.6% ± 8.2, range of 1-21/100). The mean increase to
18.9% ± 10.7 (range of 4-28/100) in 100% (19/19) of the
children post treatment was significant (P < 0.012).
Stained control smears from children presenting with
fever but lacking evidence of P. falciparum on the slides
exhibited no evidence of fragile leukocytes (Figure 2A).
Neutrophils dominated the pre-treatment leukocyte pop-
ulation with segmented neutrophils (29.3% ± 14.4, range
of 9-68/100) in 100% (21/21) of the children pre-treat-
ment and (18.4% ± 6.6, range of 2-28/100) in 100% (19/
19) of the children post treatment; the post-treatment
decrease in the mean number of segmented neutrophils
was significant (P < 0.005). Hypersegmented neutrophils
were observed in only one child (1/21). Immature neu-
trophils were found as metamyelocytes (1.3% ± 1.9, range
of 1-7/100) in 43% (9/21) of the children pre-treatment
and in 11% (2/19) of the children post-treatment (0.2% ±
0.7, range of 0-3/100) and as bands (7.2% ± 5.3, range of
Giemsa- and DAPI-stained peripheral fingerprick blood smears from children 5 years old and younger presenting with uncom- plicated malaria Figure 2
Giemsa- and DAPI-stained peripheral fingerprick blood smears from children 5 years old and younger present-
ing with uncomplicated malaria. (A) low magnification field of a control smear from a child presenting with fever but no 
detectable P. falciparum; (B) field showing neutrophil exhibiting toxic granulation and lack of a distinct nuclear membrane 
(arrowhead)and fibrous material (arrow); (C) field showing NET (arrow) and P. falciparum-infected erythrocyte with a young 
trophozoite (arrowhead); (D) higher magnification image of field from (C); (E) Fibrous aggregate interpreted to be a NET con-
taining parasitized erythrocytes (arrows); (F) Fibrous aggregate interpreted to be a NET sequestering parasitized erythrocytes; 
(G) DAPI-stained aggregate resembling fibrous structures in D and E (arrowhead) and normal neutrophil (arrow); (H) DAPI-
stained aggregate resembling fibrous structures in D and E; and (I) DAPI-stained aggregate resembling fibrous structure in F. 
Bars: A, C 100 µm; B, D-F, 10 µm.Malaria Journal 2008, 7:41 http://www.malariajournal.com/content/7/1/41
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1-21/100) in 95% (20/21) of the children pre-treatment
and in 84% (16/19) of the children post-treatment (2.7%
± 2.5, range of 1-8/100). The post-treatment drop in
bands was significant (P < 0.002), but the drop in meta-
myelocytes was only borderline significant (P < 0.053).
Neutrophils from 14 (67%) of the children exhibited
toxic granulation (Figure 2B).
Neutrophil extracellular traps
All the children exhibited evidence of aggregates of circu-
lating net-like or stranded material with adhered parasit-
ized erythrocytes and trophozoites (Figure 2C–F). The
net-like or stranded material stained with DAPI (Figure
2G–I), confirming it contains DNA. The status of the neu-
trophils and presence of DNA in the circulating aggregates
supports the conclusion that these aggregates are NETS.
This evidence for NET formation was found in 86% (18/
21) of the children pretreatment (18.5% ± 9.9, range of 6-
38/100) and in 100% (19/19) of the children post treat-
ment (14.5% ± 6.4, range of 4-26/100). The slight
decrease in the mean number of NETs post treatment was
not significant (P < 0.155).
Antinuclear antibodies
To determine whether the presence of DNA in the circulat-
ing NETs stimulated an immune response in the infected
children, levels of ANA in the samples from the 21 falci-
parum-infected children were measured before and after
SP treatment. ANA values determined for the children
infected with malaria were compared to ANA levels in a
control group of age-matched children obtained during
the season of low transmission that were slide negative for
detectable levels of trophozoites or gametocytes. Signifi-
cantly elevated ANA levels were found in 86% (18/21) of
the falciparum-infected children pre-treatment and in
100% (21/21) of the post-treatment serum samples (Fig-
ure 3A), but in only 33% (6/18) children of a control
group of children whose blood was collected in a season
of low transmission (Figure 3). Levels of ANA reactive
with dsDNA that are predictive of autoimmunity (>60 IU/
ml) were found in 81% (17/21) of the falciparum infected
children pre-treatment and post-treatment (Figure 3B).
Cytokine profiles
Pre- and post-SP treatment plasma samples from all 21
children also were evaluated by ELISA for levels of various
cytokines: IL-10, a cytokine directed toward increased Th2
activity; IL-6, a cytokine associated with an acute immune
Anti-nuclear antibody (ANA) and anti-dsDNA levels in 21 falciparum-infected children before and seven days after SP treat- ment and in age-matched uninfected children Figure 3
Anti-nuclear antibody (ANA) and anti-dsDNA levels in 21 falciparum-infected children before and seven days 
after SP treatment and in age-matched uninfected children. Samples from the infected children (A and B, Pre-Rx and 
Post-Rx) were collected during the season of high transmission. The Pre-Rx samples in (A) and (B) were collected before SP 
treatment. The Post-Rx samples in (A) and (B) were collected seven days after SP treatment. Samples from children exhibiting 
no evidence of falciparum infection were collected during a season of low transmission (A, LT). ANA Index values were calcu-
lated according to assay kit instructions and interpreted as negative, ≤0.90; equivocal, 0.91-1.09; and positive, ≥1.10. Anti-
dsDNA levels were calculated according to assay kit instructions and interpreted as negative <25 IU/ml, borderline positive: 
25-30 IU/ml, positive: 60-200 IU/ml, and high positive: >200 IU/ml.
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response; TNF a multifunctional cytokine; IL-2, a cytokine
associated with T-cell clonal expansion; IFN-γ, a NK- or
Th1 cell-mediated adaptive immune response cytokine;
TGF-β, a cytokine with immunoregulatory activity; and
CRP, an acute phase complement cascade-activating pro-
tein. Mean pre-SP treatment levels of all cytokines tested
except IL-2 were high compared to healthy US adult
standard ranges (Figure 4). Levels of IL-2 found in all pre-
and post-treatment samples were below the range of
detection in the ELISA assay.
Levels of IL-10, IL-6, TNF, IFN-γ, TGF-β, and CRP in plasma or serum drawn from 21 children ≤ 5 years old infected with P. fal- ciparum before (Pre-Rx) and 7 days after treatment with SP (Rx) Figure 4
Levels of IL-10, IL-6, TNF, IFN-γ, TGF-β, and CRP in plasma or serum drawn from 21 children ≤ 5 years old 
infected with P. falciparum before (Pre-Rx) and 7 days after treatment with SP (Rx). Individual values (n = 21) are 
represented as box plots indicating the 25th, 50th, and 75th percentile (solid lines from bottom to top of box), the 90th and 10th 
percentile values (high and low error bars respectively), and the mean value (dotted line). Closed circles represent the two 
highest values (above 90th percentile). Open circles represent the two lowest values (below 10th percentile; two open circles 
are superimposed in the plots where only one open circle is apparent). Horizontal bars on x-axes represent the upper limit of 
the range for normal healthy individuals determined with each assay kit by the manufacturer.
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Decreased parasitaemia due to SP treatment correlated
with significant decreases in the mean (and median) lev-
els of IL-10 (~30-fold decrease in mean, p = 0.000), IL-6
(~30-fold decrease in mean, p < 0.001), TNF-a (~5-fold
decrease in mean, p < 0.006), and IFN-g (~20-fold
decrease in mean, p < 0.004) (Figure 3). The dramatic
drops in these cytokine levels strongly suggest the pre-SP
treatment levels were elevated due to effects associated
with  P. falciparum trophozoite parasite infection, or
cytokine inhibition by SP. SP treatment had no significant
effect on the post-treatment levels of either TGF-b (p <
0.607) or CRP (p < 0.023) after seven days (Figure 3).
IL-6 levels strongly correlated with the erythrocyte
Rouleaux aggregation phenomenon (Cramer's V = .36, p
= .104, data not shown) and very strongly correlated with
the presence of extracellular fibers (Cramer's V = 0.6, p =
.006), which appeared to coat circulating erythrocytes and
sequester free-circulating parasites (Figure 2G–I). Extracel-
lular fibers were observed in 13 (62%) of these children,
many of whom demonstrated appliqué forms (Figure 2H)
of advanced stage P. falciparum trophozoites [52].
Further analysis of the pre-SP treatment samples revealed
that grouping the samples according to child age revealed
significant differences (p = 0.078) in mean levels of only
one of the cytokines tested IFN-γ (group data not shown
separately). The ten children under 24 months old had a
mean IFN-γ level of 190 pg/ml (SD ± 338 pg/ml), with
undetectable levels in only two of those children (25% of
children under 24 months old), whereas the eleven chil-
dren 24 to 60 months old had a mean IFN-γ level of 0.47
pg/ml (SD ± 1.1 pg/ml), with undetectable levels in eight
of those children (73% of the children over 24 months
old). Analysis of individual pre-SP treatment samples
revealed that one child, a one-year old female, had the
highest levels of IL-6 and TNF (highest of the two outlier
points in both Figure 4 box plots), the next to highest level
of IL-10 (the second highest outlier point in the Figure 4,
IL-10 box plot), and the next to highest IFN-γ (the second
highest outlier point in the Figure 4, IFN-γ box plot).
Relating multiple variables in the pre-SP-treatment sam-
ples revealed a triad correlation only for levels of IL-6, IL-
10, and TNF (Figure 5). The effect of IL-6, while control-
ling for IL-10, on TNF is statistically significant (virtually
without random sampling error; p = 0.009, r = 0.852, r2 =
0.726). Relating TGF-β levels to CRP levels revealed a
moderately strong inverse correlation (p = 0.005, r = 0.6,
r2 = 0.353) (Figure 6).
Elevated TNF-a levels which did not exceed 324 pg/ml
(20/21 children) correlated with NET formation (r2 =
0.512) quantified by the leukocyte differential percentage
of NETs and smudge forms determined by peripheral slide
analysis (Figure 7). Analysis of individual pre-SP treat-
ment samples revealed that the one year-old female
described earlier generated the single outlier point.
Discussion
Mechanisms underlying malaria-associated immune
hyporesponsiveness and pathogenesis remain unclear [4].
This investigation relates leukocyte differential counts, cir-
culating NETs, cytokine profiles, and ANA levels to help
elucidate these mechanisms in falciparum malaria patho-
Relationship of CRP and TGF-β levels in 21 falciparum- infected children before SP treatment Figure 6
Relationship of CRP and TGF-β levels in 21 falci-
parum-infected children before SP treatment. CRP 
levels exhibits a modest inverse relationship with TGF-β lev-
els. Line, regression line (r2 = 0.353).
-2.5
0
2.5
5
7.5
10
-5
C
R
P
 
(
P
g
/
m
l
)
15
12.5
0 1 01 52 02 53 03 54 04 55 0 5
TGFE (ng/ml)
Triad relationship of TNF, IL-10, and IL-6 levels Figure 5
Triad relationship of TNF, IL-10, and IL-6 levels. Rela-
tionships of TNF with IL-10 (open circles) and with IL-6 
(closed circles) are plotted for each of the 21 patients. The 
additive combinatorial effect of elevated IL-6 and IL-10 
cytokine levels on TNF is significant (without random sam-
pling error). Line, multivariate regression line (r2 = 0.726).
600
500
(
p
g
/
m
l
)
400
300
-100
0
100
200
T
N
F
D
-200 0 200 400 600 800 1000 1200 1400 1600 1800
IL-10 or   IL-6 (pg/ml)Malaria Journal 2008, 7:41 http://www.malariajournal.com/content/7/1/41
Page 9 of 12
(page number not for citation purposes)
genesis in young children residing in sub-Saharan African
pockets of endemicity. For this investigation, World
Health Organization-trained drug sensitivity testing team
members [46] prepared fingerprick peripheral blood
smears and obtained blood samples before and seven
days after treatment with sulfadoxine-pyrimethamine
(SP) from 21 Nigerian northern plateau children five
years old and younger diagnosed with clinically-uncom-
plicated, slide-positive falciparum malaria.
The peripheral slide analysis revealed that all 21 children
exhibited some degree of leukocyte pathology including
abnormal neutrophils. In the innate immune response,
neutrophils can use phagocytosis to kill microbes intracel-
lularly or NET formation to kill microbes extracellularly.
To form a NET, the nucleus of an activated neutrophil
loses its classic lobular appearance as the nuclear mem-
brane dissolves mixing chromatin with cytoplasmic gran-
ules. The neutrophil plasma membrane then ruptures,
releasing the chromatin and adherent granule proteins as
a coherent NET or in some cases as less organized extracel-
lular fibers [53]. NETs composed of a chromatin scaffold
decorated with granule proteins have been shown to kill
gram positive and gram negative bacteria as well as some
fungi [37,38,40,42,53,54]. In this investigation, various
stages of NET formation with bound falciparum parasites
were found on the peripheral blood smear slides from the
falciparum-infected children. Evidence for NET circula-
tion and involvement in the immune response to falci-
parum infection has not been previously reported. It
remains to be determined whether NET association leads
to falciparum parasite destruction.
In addition to possibly killing the parasites, release of neu-
trophil self-DNA in the NETs found in this investigation
could induce autoimmunity, which in turn may contrib-
ute to acute severe pathogenesis in young children. In sys-
temic lupus erythematosus, for example, the adjuvant
activity of released self-DNA contributes to production of
ANA either through an acute response involving comple-
ment-fixing antibodies against DNA or nucleoprotein-
DNA complexes [19,23,55] or through a Th2-mediated
IgG-induced humoral response [55-57]. General ANA lev-
els, as well as IgG anti-dsDNA ANA diagnostic of an
autoimmune response, were found in samples collected
during the season of high malaria transmission from all
the children in this study (86% pre-treatment and 100%
post-treatment, 81% pre-treatment and 81% post-treat-
ment; general ANA versus specific IgG dsDNA ANA,
respectively). Autoimmune reactions to self-DNA from
neutrophil shadow cells of Gumprecht and lymphocyte
smudge cells contribute to certain noncancerous leuke-
mias [50,51]. The elevated number of metamyelocytes
found in some of the falciparum-infected children in this
study may reflect autoimmune activity.
Once produced, ANA may contribute to malarial patho-
genesis through formation of immune complexes that
induce renal anomalies and hyperuraemia [58-60] or
impair leukocyte function [59]. Moreover, NET adherence
to parasitized and nonparasitized erythrocytes, as found
in this investigation, could generate a break in tolerance
and induce a carrier effect anti-erythrocyte Th1 cell-medi-
ated activity leading to severe anaemia [31,61]. Although
all the children in this study had a packed red cell volume
greater than 25% and, therefore, were not classified as
anaemic [47], the presence of burr cells, acanthocytes, hel-
met cells, and schistocytes on the peripheral blood slides
depicted a predisposition to anaemia. As the disease
progresses, anti-erythrocyte activity could cause erythro-
cyte sequestration contributing to development of the
microvascular occlusion associated with fatal cerebral
malaria [26].
The elevated TNF levels found in this study were coinci-
dent with NETs. It is possible that the distinct cytokine
profile (the high TNF/Il-6/Il-10 triad relationship with
high levels of persistent TGF-β and CRP in the absence of
Il-2) and the consistent presence of ANAs found here may
represent the NET immunologic response to malaria in
this sub-Saharan pocket of endemicity [62].
A moderately strong inverse correlation between TGF-β
and CRP was found before and after treatment in this
investigation. TGF-β-treated neutrophils produce reactive
oxygen species (ROS), which are necessary for NET forma-
tion [40], while CRP inhibits neutrophil chemotaxis and
production of ROS [63]. CRP participates in opsonization
Relationship between the presence of NETs and elevated  TNF levels Figure 7
Relationship between the presence of NETs and ele-
vated TNF levels. Levels of abnormal leukocytes exhibit a 
positive relationship with elevated TNF levels. Line, regres-
sion line (r2 = 0.512).
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and increased clearance of damaged cells, including
opsonized erythrocytes and/or damaged leukocytes, by
the classical pathway [20,22,64]. In children with low
CRP levels, lack of such protection may permit a lack of
clearance of debris and a progression from uncomplicated
to severe malaria. Further studies are needed to determine
the extent of the inverse relationship between TGF-β and
CRP in other age groups within this population to deter-
mine whether there is a critical ratio threshold where the
balance between the normal activities of TGF-β [65] and
CRP [63,66] is lost. In the future, TGF-β activity will be
confirmed by measuring levels of IgA resulting from
immunoglobulin class-switch.
NET formation and ANA production in older individuals
with more adapted immune systems in a population
chronically exposed through high seasonal malaria trans-
mission could produce a very different outcome. In the
adult population over time, the novel presentation of the
parasites captured by NETs could induce a carrier-hapten
type of humoral and cellular immune induction similar to
that produced by the adjuvant effect of certain bacterial
and parasite DNAs [67]. Self-DNA interaction with Toll-
like receptor 9 (TLR9), which stimulates IL-12-IFN-γ-
dependent activation of Th1 cells, could stimulate
immune response not only to the DNA complexes but
also to the captured falciparum parasites. Such an adap-
tive mechanism of protection is consistent with the obser-
vation that elevated IL-12 levels are associated with less
severe malaria in adults [33]. Cross reacting activation of
Th1 and Th2 mechanisms through toll-like receptors has
been associated with CpG adjuvant activity [67].
Transition of infected children from autoimmune patho-
genesis to autoimmune protection may depend on devel-
oping the ability to mount a T cell independent pathogen
associated molecular pattern (PAMP) response. The lack
of detectable IL-2 in the children with uncomplicated fal-
ciparum malaria in this study could be because it is bound
to a soluble IL-2 receptor and missed by the assay [62].
Alternatively, it may represent a lack of Th1 and Th2
clonal expansion, with a shift to NET-induced activation
[68] through Toll-like receptors. If NET DNA binds to
TLR9 and the ANA that is present in the children binds to
IgG receptors, dendritic cells may cross present both
major histocompatibility complexes I and II, thereby
enhancing both humoral- and cell-mediated immune
responses. As the ability of the child to mount a PAMP
immune response develops, this autoimmune activity
may become protective against the parasite by activating T
cytotoxic cell activity [44]. Development of NET-induced
PAMP activity therefore could explain the paradox that
high IFN-γ levels are associated with severe malaria in
young children who have low IL-10 levels [5] but also
associated with decreased malarial morbidity in adults
who have elevated IL-12 levels associated with an adap-
tive Th1 [33] and Th2 response [67].
Ironically, development of ANA, as found in the children
assessed in this investigation, may bind well enough to
CpG to neutralize its adjuvant activity. This could contrib-
ute to immune hyporesponsiveness [4] and affect the out-
come in CpG adjuvant-based vaccines [43].
Conclusion
This investigation of blood samples from 21 children in a
mesoendemic region of sub-Saharan Africa with uncom-
plicated falciparum malaria provides evidence for the for-
mation of circulating NETs that can capture the
falciparum parasites and stimulate production of ANA. In
conjunction with leukocyte differential counts and
cytokine profiles, the presence of the NETs and ANA sup-
ports the premise that falciparum-induced autoimmune
activity contributes to pathogenesis in the children, but
may provide a TNF-based mechanism of protection
through recurrent PAMP activation during chronic expo-
sure over time [44].
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